Born in Linz, Austria

2000 - 2003: Education in General Medicine

2003 - 2008: Specialisation in Internal Medicine

2008 - 2010: Subspecialisation in Gastroenterology and Hepatology

2010: Associate Professor of Internal Medicine

2010 - 2013: Subspecialisation in Endocrinology and Metabolism

Since 2011: Senior physician and Head of the Liver Unit, St. Vincent Hospital Vienna

Since 2011: Vice head of the Department of Interventional Endoscopy, St. Vincent Hospital Vienna

Publications

1. Z. Messner, M. Gschwantler, H. Resch, G. Bodlaj. Use of the Ella Danis stent in severe esophageal bleeding caused by acute necrotizing esophagitis. Endoscopy 2014;46 Suppl 1:E225-226.
2. G. Bodlaj, G. Biesenbach. Higher mortality of patients on haemodialysis with pancreatic diabetes compared to type 2-diabetes. Diabetol Metab Syndr 2012;4:9.
3. S. Beinhardt, JH Aberle, M. Strasser, E. Dulic-Lakovic, A. Maieron, A. Kreil, K. Rutter, AF Staettermayer, C. Datz, TM Scherzer, R. Strassl, M. Bischof, R. Stauber, G. Bodlaj, H. Holzmann, P. Steindl-Munda, P. Ferenci, H. Hofer. Serum level of IP-10 increases predictive value of IL28B polymorphism for spontaneous clearance of acute HCV infection. Gastroenterology 2012;142:78-85.
4. G. Biesenbach, G. Bodlaj, H. Pieringer, M. Sedlak. Clinical versus histological diagnosis of diabetic nephropathy - is renal biopsy required in type 2 diabetic patients with renal disease? QJM 2011;104:771-774.
5. G. Biesenbach, G. Bodlaj, S. Ebner, P. Biesenbach, H. Pieringer. Metabolic control and vascular diseases under oral antidiabetic drug versus insulin therapy and/or diet alone during he first year of hemodialysis in type 2 diabetic patients with ESRD. Int Urol Nephrol 2011;43:1155-1160.
6. G. Bodlaj, R. Hubmann, K. Saleh, T. Stojakovic, G. Biesenbach, J. Berg. Alkaline phosphatase predicts relapse in chronic hepatitis C patients with end-of-treatment response. World J Gastroenterol 2010;16:2407-2410.
7. G. Bodlaj, R. Hubmann, R. Pichler, K. Saleh, T. Stojakovic, G. Biesenbach, J. Berg. Thyroid hormones in MARS treated patients with Child C cirrhosis: a case series. Liver Int 2010;30:927-928.
8. G. Biesenbach, G. Bodlaj, H. Pieringer. Gender-associated differencesin weight gain, insulin requirement and metabolic control in newly insulin-treated type 2 diabetic patients with secondary sufonylurea failure - a one-year observation. Clinical Medicine: Endocrinology and Diabetes 2009;2:75-80.
9. G. Bodlaj, R. Hubmann, K. Saleh, G. Biesenbach, E. Pohanka, T. Stojakovic, J. Berg. Serum levels of N-terminal pro-B-type natriuretic peptide are associated with allograft function in recipients of renal transplants. Wien Klin Wochenschr 2009;121:631-637.
10. S. Stieglmayr, A. Hayat Khayyat, G. Bodlaj, H. Pieringer, G. Biesenbach. Comparable outcomes in type 2 diabetic patients with diabetic or vascular nephropathy treated by hemodialysis. Nephron Clin Pract 2010;114:c104-c107.
11. G. Biesenbach, G. Bodlaj, M. Sedlak, H. Pieringer, G. Kiesling. Exercise program for older patients with insulin-treated type 2 diabetes: long-term effects on metabolic control and BMI. Z Gerontol Geriatr 2009;42:465-469.
12. G. Biesenbach, G. Bodlaj, H. Pieringer. Low BMI is a prognostic predictor in pre-dialysis patients with type 2 diabetes. Clin Nephrol 2009;71:235-237.
13. G. Biesenbach, G. Bodlaj, H. Pieringer, A. Raml. Insulin requirement after one year of insulin therapy in type 2 diabetic patients dependent on fasting C-peptide. Neth J Med 2008;66:259-260.
14. G. Biesenbach, P. Biesenbach, G. Bodlaj, H. Pieringer, B. Schmekal, O. Janko, R. Margreiter. Impact of smoking on progression of vascular disease and patient survival in type-1 diabetic patients after simultaneous kidney-pancreas transplantation in a single centre. Transplant Int 2008;21:357-363.
15. G. Biesenbach, G. Bodlaj, H. Pieringer, M. Sedlak. Influence of residual diuresis on insulin requirement in insulin-treated type 2 diabetic patients during the first year of hemodialysis. Nephrol Dial Transplant 2008;23:422-423.
16. G. Bodlaj, R. Pichler, W. Brandstätter, M. Hatzl, W. Maschek, G. Biesenbach, J. Berg. Hyperthyroidism affects arterial stiffness, plasma NT-pro-B-type natriuretic peptide levels and subendocardial perfusion in patients with Graves´ disease. Ann Med 2007;39:608-616.
17. G. Bodlaj, J. Berg, G. Biesenbach. Diurnal Variation of Pulse Wave Velocity Non-Invasively Assessed by Applanation Tonometry in Young Healthy Men. Yonsei Med J 2007;48:665-670.
18. G. Biesenbach, G. Bodlaj, H. Pieringer. Weight gain and Metabolic Control in Patients With Type 2 Diabetes. Can J Diabetes 2006;30:384-389.
19. G. Bodlaj, J. Berg, R. Pichler, G. Biesenbach. Prevalence, severity and predictors of HOMA-estimated insulin resistance in diabetic and non-diabetic patients with end-stage renal disease. J Nephrol 2006;19:607-612.
20. R. Hubmann, G. Bodlaj, M. Czompo, L. Benkoe, P. Pichler, S. Al-Kattib, P. Kiblböck, A. Shamiyeh. G. Biesenbach. The use of self-expanding metal stents to treat acute esophageal variceal bleeding. Endoscopy 2006;38:896-901.
21. G. Bodlaj, M. Stöcher, P. Hufnagl, R. Hubmann, G. Biesenbach, H. Stekel, J. Berg. Genotyping for the Lactase-Phlorizin Hydrolase-13910 Polymorphism by LightCycler PCR and Implications for the Diagnosis of Lactose Intolerance. Clin Chem 2006;52:148-151.
22. G. Bodlaj, J. Berg, G. Biesenbach. Diurnal Variation of Arterial Stiffness and Subendocardial Perfusion Noninvasively Assessed Using Applanation Tonometry in Young Healthy Men. Wien Klin Wochenschr 2005;117:348-352.
23. G. Bodlaj, J. Berg, R. Pichler, T. Sailer, G. Biesenbach. Type 2 diabetes in patients with end-stage renal disease is not associated with further increased serum inflammatory parameters. J Nephrol 2004;17:112-117.
24. E. Cauza, J. Kletzmaier, G. Bodlaj, A. Dunky, W. Herrmann, K. Kostner. Relationship of non-LDL-bound apo(a), urinary apo(a) fragments and plasma Lp(a) in patients with impaired renal function. Nephrol Dial Transplant 2003;18:1568-1572.
25. U. Hoffmann, G. Bodlaj, K. Derfler, C. Bernhard, L. Wicke, C. J. Herold, K. Kostner. Quantification of coronary artery calcification in patients with FH using EBCT. Eur J Clin Invest 2001;31:471-475.
26. G. Bodlaj. Statine in der Prävention des ischämischen zerebralen Insults. J Kardiol 2000;9:325-327.
27. K. Kostner, M. Clodi, G. Bodlaj, U. Hoffmann, K. Hermann, G. Maurer, R. Pacher, W. H. Hörl. Urinary apo(a) excretion is not altered by changes in glomerular filtration rate and renal plasma flow in healthy males. Wien Klin Wochenschr 2000;112:121-125.
28. M. Clodi, R. Oberbauer, G. Bodlaj, J. Hofmann, G. Maurer, K. Kostner. Urinary excretion of apolipoprotein (a) fragments in type 1 diabetes mellitus patients. Metabolism 1999;48:369-372.
29. K. Kostner, S. Banyai, M. Banyai, G. Bodlaj, G. Maurer, K. Derfler, W. H. Hörl, R. Oberbauer. Urinary apolipoprotein (a) excretion in patients with proteinuria. Ann Med 1998;30:497-502.
30. K. Kostner, M. Clodi, G. Bodlaj, B. Watschinger, W. Hörl, K. Derfler, K. Huber. Decreased urinary apolipoprotein (a) excretion in patients with impaired renal function. Eur J Clin Invest 1998;28:447-452.
31. G. Bodlaj, J. Hofmann, A. Gharehgozloo, G. Maurer, K. Huber, K. Kostner. Erhöhter oxidativer Streß bei Patienten mit instabiler Angina pectoris. J Kardiol 1998;6:279-286.